1. Home
  2. VYGR vs AVNW Comparison

VYGR vs AVNW Comparison

Compare VYGR & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • AVNW
  • Stock Information
  • Founded
  • VYGR 2013
  • AVNW 2006
  • Country
  • VYGR United States
  • AVNW United States
  • Employees
  • VYGR N/A
  • AVNW N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • Sector
  • VYGR Health Care
  • AVNW Technology
  • Exchange
  • VYGR Nasdaq
  • AVNW Nasdaq
  • Market Cap
  • VYGR 231.9M
  • AVNW 274.4M
  • IPO Year
  • VYGR 2015
  • AVNW 2007
  • Fundamental
  • Price
  • VYGR $4.21
  • AVNW $24.13
  • Analyst Decision
  • VYGR Strong Buy
  • AVNW Strong Buy
  • Analyst Count
  • VYGR 8
  • AVNW 5
  • Target Price
  • VYGR $16.71
  • AVNW $37.60
  • AVG Volume (30 Days)
  • VYGR 635.7K
  • AVNW 119.5K
  • Earning Date
  • VYGR 11-11-2025
  • AVNW 09-10-2025
  • Dividend Yield
  • VYGR N/A
  • AVNW N/A
  • EPS Growth
  • VYGR N/A
  • AVNW N/A
  • EPS
  • VYGR N/A
  • AVNW 0.10
  • Revenue
  • VYGR $42,580,000.00
  • AVNW $434,606,000.00
  • Revenue This Year
  • VYGR N/A
  • AVNW $7.15
  • Revenue Next Year
  • VYGR $107.07
  • AVNW $6.61
  • P/E Ratio
  • VYGR N/A
  • AVNW $240.10
  • Revenue Growth
  • VYGR N/A
  • AVNW 6.50
  • 52 Week Low
  • VYGR $2.65
  • AVNW $12.96
  • 52 Week High
  • VYGR $8.28
  • AVNW $26.83
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 62.64
  • AVNW 57.60
  • Support Level
  • VYGR $3.91
  • AVNW $22.07
  • Resistance Level
  • VYGR $4.51
  • AVNW $26.25
  • Average True Range (ATR)
  • VYGR 0.27
  • AVNW 1.07
  • MACD
  • VYGR 0.05
  • AVNW 0.22
  • Stochastic Oscillator
  • VYGR 74.79
  • AVNW 54.41

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

Share on Social Networks: